Come up with a name for your new list and we'll add to it:
Pulmagen Therapeutics raised a round of funding on , . Investors include
MVM Life Science Partners.
Pulmagen develops novel and proprietary drugs for chronic respiratory diseases including COPD and asthma. These therapies aim to deliver both improved bronchodilator symptomatic relief and treat the u…